BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38402559)

  • 1. Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method-A prospective study.
    Lee SY; Ahn YS; Moon HW
    Helicobacter; 2024; 29(1):e13056. PubMed ID: 38402559
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
    Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GastroPanel® Biomarker Assay: The Most Comprehensive Test for
    Syrjänen K; Eskelinen M; Peetsalu A; Sillakivi T; Sipponen P; Härkönen M; Paloheimo L; Mäki M; Tiusanen T; Suovaniemi O; DiMARIO F; Fan ZP
    Anticancer Res; 2019 Mar; 39(3):1091-1104. PubMed ID: 30842138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    Hamashima C; Sasazuki S; Inoue M; Tsugane S;
    BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
    Chapelle N; Petryszyn P; Blin J; Leroy M; Le Berre-Scoul C; Jirka I; Neunlist M; Moussata D; Lamarque D; Olivier R; Tougeron D; Mosnier JF; Matysiak-Budnik T
    Helicobacter; 2020 Oct; 25(5):e12727. PubMed ID: 32700438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test-negative individuals.
    Sheng C; Sun L; Lyu Z; Li L; Zhang Y; Zhang Y; Zhang Y; Dai H; Huang Y; Song F; Yuan Y; Chen K
    Helicobacter; 2023 Jun; 28(3):e12966. PubMed ID: 36941759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ABC (D) stratification for screening patients with gastric cancer.
    Kudo T; Kakizaki S; Sohara N; Onozato Y; Okamura S; Inui Y; Mori M
    World J Gastroenterol; 2011 Nov; 17(43):4793-8. PubMed ID: 22147980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC Classification Is Less Useful for Older Koreans Born before 1960.
    Kwon H; Lee SY; Kim JH; Lee SP; Kim JH; Sung IK; Park HS; Shim CS
    Gut Liver; 2019 Sep; 13(5):522-530. PubMed ID: 30970432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Related to Upper Gastrointestinal Symptom Generation in 2275 Helicobacter pylori Seroprevalent Adults.
    Lee SP; Lee SY; Kim JH; Sung IK; Park HS; Shim CS
    Dig Dis Sci; 2017 Jun; 62(6):1561-1570. PubMed ID: 28281170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer.
    Shiota S; Mahachai V; Vilaichone RK; Ratanachu-Ek T; Tshering L; Uchida T; Matsunari O; Yamaoka Y
    J Med Microbiol; 2013 Oct; 62(Pt 10):1571-1578. PubMed ID: 23831768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
    Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
    Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer.
    Kishino T; Oyama T; Tomori A; Takahashi A; Shinohara T
    Intern Med; 2020 Jun; 59(12):1473-1480. PubMed ID: 32188803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.